Laparoscopic Radiofrequency Ablation Combined With Laparoscopic Liver Resection for More Than One HCC on Cirrhosis
Liver Cirrhosis
Male
Carcinoma, Hepatocellular
Liver Neoplasms
Combined Modality Therapy
Embolization, Therapeutic
3. Good health
03 medical and health sciences
0302 clinical medicine
Catheter Ablation
Hepatectomy
Humans
Laparoscopy
Neoplasm Recurrence, Local
Tomography, X-Ray Computed
Aged
DOI:
10.1097/sle.0b013e31806d9c65
Publication Date:
2007-08-15T07:01:52Z
AUTHORS (7)
ABSTRACT
The management of patients affected by more than one hepatocellular carcinoma (HCC) is still controversial but nowadays a multimodal approach to this pathology seems be the most effective and versatile therapeutic option. When orthotopic liver transplantation not indicated, survival-time quality life improvement goal for who will have long metabolic oncologic disease history. Combined use minimally invasive nonsurgical treatments [percutaneous ethanol injection, radiofrequency ablation, transcutaneous arterial chemioembolization (TACE)] allows offer advantages each procedure reducing their individual side effects complications. We consider laparoscopy as procedure, which can benefits surgical treatment, tumor removing, with an improved postoperative course. If recurrence risk factors are present, costs/benefits rapport decreased laparoscopic offers, in addition radical resection, pain, reduced trauma abdominal wall, smaller incisions, peritoneal adhesions and, selected cases, earlier beginning chemiotherapy. report case patient HCC bigger lesion 50 mm protruding from hepatic segment III, subcapsular located at V, deep VII-VIII. was submitted double resection association ablation. Five months later, presented early malignancy that treated TACE. At 8 another multifocal 2 years apparent good conditions acceptable life. think could gain considerable place treatment cirrhotic because, it offers lower complications rate.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (24)
CITATIONS (11)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....